Siemens Healthineers (OTCMKTS:SMMNY) Stock Dropped to Strong Sell by Zacks Research

Siemens Healthineers (OTCMKTS:SMMNY) was downgraded by research analysts at Zacks Research from a “hold” rating to a “strong sell” rating in a research note issued on Thursday, Zacks reports.

A number of other brokerages also recently issued reports on SMMNY. Deutsche Bank Aktiengesellschaft restated a “hold” rating on shares of Siemens Healthineers in a research note on Tuesday, August 18th. Citigroup reissued a “buy” rating on shares of Siemens Healthineers in a report on Thursday, August 27th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, Siemens Healthineers has a consensus rating of “Moderate Buy”.

Siemens Healthineers Stock Performance

OTCMKTS SMMNY opened at $21.29 on Thursday. The business has a 50 day moving average price of $22.24 and a 200-day moving average price of $21.06. Siemens Healthineers has a 52 week low of $19.20 and a 52 week high of $28.92.

About Siemens Healthineers

Siemens Healthineers AG is a Germany-based medical technology company that develops and supplies products, services and digital solutions for healthcare providers. Its portfolio supports medical imaging, laboratory diagnostics, cancer treatment, minimally invasive procedures and related clinical workflows.

The company’s imaging business offers magnetic resonance imaging, computed tomography, molecular imaging, X-ray and ultrasound systems. Its diagnostics activities include laboratory testing, point-of-care testing and diagnostic IT solutions.